Elsevier可供选择的文章格式模版Word格式文档下载.docx

上传人:b****5 文档编号:8453600 上传时间:2023-05-11 格式:DOCX 页数:11 大小:29.43KB
下载 相关 举报
Elsevier可供选择的文章格式模版Word格式文档下载.docx_第1页
第1页 / 共11页
Elsevier可供选择的文章格式模版Word格式文档下载.docx_第2页
第2页 / 共11页
Elsevier可供选择的文章格式模版Word格式文档下载.docx_第3页
第3页 / 共11页
Elsevier可供选择的文章格式模版Word格式文档下载.docx_第4页
第4页 / 共11页
Elsevier可供选择的文章格式模版Word格式文档下载.docx_第5页
第5页 / 共11页
Elsevier可供选择的文章格式模版Word格式文档下载.docx_第6页
第6页 / 共11页
Elsevier可供选择的文章格式模版Word格式文档下载.docx_第7页
第7页 / 共11页
Elsevier可供选择的文章格式模版Word格式文档下载.docx_第8页
第8页 / 共11页
Elsevier可供选择的文章格式模版Word格式文档下载.docx_第9页
第9页 / 共11页
Elsevier可供选择的文章格式模版Word格式文档下载.docx_第10页
第10页 / 共11页
Elsevier可供选择的文章格式模版Word格式文档下载.docx_第11页
第11页 / 共11页
亲,该文档总共11页,全部预览完了,如果喜欢就下载吧!
下载资源
资源描述

Elsevier可供选择的文章格式模版Word格式文档下载.docx

《Elsevier可供选择的文章格式模版Word格式文档下载.docx》由会员分享,可在线阅读,更多相关《Elsevier可供选择的文章格式模版Word格式文档下载.docx(11页珍藏版)》请在冰点文库上搜索。

Elsevier可供选择的文章格式模版Word格式文档下载.docx

oArticleinfo(articlehistory+keywords)

oCorrespondingauthorsection

oRunningheaders

-MainText

-BackMatter

oFootnote(ifany)

oAcknowledgments(ifany)

oConflictofInterestStatement(ifany)

oFundingStatement(ifany)

oReferences

oTables+legends(ifany)

oFigures+legends(ifany)

oAppendix(es)(ifany)

3.FRONTMATTER

3.1.Citationinformation

-Citationinformationislistedas:

JournalofOrthopaedics,TraumaandRehabilitationxxx(2000)1–3

3.2.AnEnglisharticletitle+aChinesearticletitle

-Eachwordlongerthan3lettersiscapitalized

-Firstwordaftercolonoremdashisalsocapitalized

oe.g.NovelSwine-originInfluenzaVirusA(H1N1):

TheFirstPandemicofthe21stCentury

3.3.AuthorNames

-Authornamesarespelledoutinfullandseparatedbycommas

-Familyname(surname)appearslast,e.g.Fan-HaoChou

-Affiliationsareindicatedbysuperscriptednumbersplacedafterthecomma

-Ifanauthorhasmorethanoneaffiliation,thesuperscriptednumbersareseparatedbyacomma(closedup)

-Thereisanasterisktoindicatethecorrespondingauthor

-Use†aftertheaffiliationtoindicateco-firstauthors

oEXAMPLE:

-

3.4.Authoraffiliations

-Eachaffiliationstartanewline,andhascompletedetailsincludingthecityandcountry

-ThereisNOstreetaddressinthissection

-Correspondinglowercaseletterslinkingeachaffiliationtoauthorsareplacedatthebeginningofeachaffiliation

-Thereisaperiodattheendoftheaffiliations

3.5.AnEnglishabstract+aChineseabstract

-Thereisan“Abstract”heading

-ArticlesinthecategoriesofReviewArticle,CaseReportandLettertotheEditorhaveunstructuredabstractsinonesingleparagraph

-AbstractsofOriginalArticlesarestructuredwithsectionheadings:

“Background/Purpose(s):

”,“Methods:

”,“Results:

”,and“Conclusion:

-Abstractsshouldbenolongerthan150wordsinEnglishAbstract

-Whereaterm/definitioniscontinuallyreferredto(≥3times),itiswritteninfullwhenitfirstappears,followedbythesubsequentabbreviationinparentheses;

thereafter,theabbreviationisused

3.6.Articleinfo(articlehistory+keywords)

∙Thereare3dates:

Received,Revised,Accepted

∙Datesareintheformat:

“2January2008”

∙Thewordintheheading“Keywords:

”iscapitalized

∙Keywordsareinalphabeticalorderandseparatedbycommas

∙Thereisnoperiodafterthelastkeyword

∙Upto5keywordsareallowed

∙Keywordsareinlowercaseonly(unlessitisapropernoun,speciesname)

3.7.Correspondingauthorsection

-“*Correspondingauthor.”followedbythecorrespondingauthor’semailaddress.

-Theasteriskbeforethe““Correspondingauthor.””isnotsuperscripted.

-E-mailaddressisonthenextline.“E-mail”ishyphenated,andallhyperlinkshouldberemoved.

-Ifmorethan1correspondingauthor,use“(author’sname)”toseparatethecorrespondingauthors’e-mail.

-Ifthereareco-firstauthors,onthenextlineisthephrase:

“†xxxandxxxcontributedequallytothiswork.”

-Tel/faxnumbersandmailingaddressshouldbedeleted

3.8.Runningtitle

-Runningarticletitleisnomorethan50charactersinlengthandonlyfirstwordiscapitalized(unlesswordisapropernoun,speciesname),e.g.Occludingeffectonhumandentinaltubules

-Runningauthornamesuseinitialsfollowedbyperiod(closedup)thensurnames;

“etal”(withoutperiod)isusedwhenthereare≥3authors,e.g.

o1author:

S.L.Cheng

o2authors:

S.L.Cheng,P.C.Hsiung

o3authors:

S.L.Cheng,etal

4.MAINTEXT

4.1.SectionHeadings

-Numbered

-OriginalarticlesandCasereportsgenerallyusetheseLevelIheadings:

Introduction,MaterialsandMethods,Results,Discussion,Acknowledgments(ifany),ConflictofInterestStatement(ifany),FundingStatement(ifany),References

-Dependingonthemanuscript,theremaybeLevelIIheadings

o1.Introduction

o2.MaterialsandMethods

o2.1.Patients

o2.2.Studyprotocol

o2.3.Statisticalanalysis

o3.Results

o4.Discussion(ResultsandDiscussion)

o5.Acknowledgments(ifany)

o6.References

-ReviewArticlesdonothaverestrictedsectionheadingsbutshouldbeappropriatetoeachsectionofthearticle

-LevelIheadings:

eachwordlongerthan3lettersiscapitalized,inboldfont,with1linesofspacebeforeitand1lineofspaceafterit

-LevelIIheadings:

onlyfirstwordiscapitalized,inboldfont,with1lineofspacebeforeitand0linesofspaceafterit

-LevelIIIheadings:

onlyfirstwordiscapitalized,with1lineofspacebeforeitand0linesofspaceafterit

-ButifitfollowsimmediatelyafteraLevelIIheading,thenthereis0linesofspacebeforeitand0linesofspaceafterit

4.2.Paragraphs

-Firstparagraphunderanylevelofsectionheadingisindented

-Subsequentparagraphsareindented

4.3.Abbreviations

-Whereaterm/definitioniscontinuallyreferredto(i.e.≥3timesinthetext),itiswritteninfullwhenitfirstappears,followedbythesubsequentabbreviationinparentheses(evenifitwaspreviouslydefinedintheabstract);

-Ensurethatanabbreviationsodefineddoesactuallyappearlaterinthetext(excludinginfigures/tables),otherwise,itshouldbedeleted

-Abbreviationslist(Pleasereferto:

Dorland’smedicalAbbreviations.Philadelphia:

Saunders,1992.)

4.4.DrugNames

-Thegenerictermforalldrugsandchemicalsshouldbeused,unlessthespecifictradenameofadrugisdirectlyrelevanttothediscussion

4.5.Genenomenclature

-Currentstandardinternationalnomenclatureforgenesshouldbeadheredto

-Genesshouldbetypedinitalicfontandincludetheaccessionnumber

-Forhumangenes,usegeneticnotationandsymbolsapprovedbytheHUGOGeneNomenclatureCommittee(http:

//www.genenames.org/)orrefertoPubMed(http:

//www.ncbi.nlm.nih.gov/sites/entrez)

-TheHumanGenomeVariationSocietyalsohasausefulsitethatprovidesguidanceinnamingmutationsathttp:

//www.hgvs.org/mutnomen/index.html

4.6.Numbers

-Numbersthatbeginasentenceorthose<

10(i.eonetonine)arespelledoutusingletters

-Laboratoryparameters,time,temperature,length,area,mass,andvolumeareexpressedusingdigits

-Centuriesanddecadesarewrittenoutusingdigits,e.g.the1980sor19thcentury[note:

superscripted“th”]

-Numberswithinparenthesesareexpressedindigitsevenif<

10

-Acommaisusedasathousandseparator,e.g.“10,581”,“6,293,470”

4.7.Statistics

-Student’sttestNOTStudent’st-test

-χ2testNOTChi-squaredtest[note:

χisNOTinitalics]

-Cronbach’sαNOTCronbach’sαlphaoralfa

-ANOVAisspelledoutinfullasanalysisofvariance

-ANCOVAisspelledoutinfullasanalysisofcovariance

-Forsamplesize,the“n”isanitalicizedlowercaseletter,withaspaceoneitherside:

n=36

-Forpvalues,the“p”isanitalicizedlowercaseletter,withaspaceoneitherside:

p<

0.05,p=0.562

-pshouldNEVERstartasentence:

“p<

0.05wastakentobesignificant.”shouldberewrittenas“Apvalue<

0.05wastakentobesignificant.”

-Thereisazerobeforedecimalpoints,e.g.0.75NOT.75

4.8.Units

-Systè

meInternational(SI)unitsareused

-Metricsystemisusedfortheexpressionoflength,area,mass,andvolume

-BloodpressurevaluesarereportedinmmHg[note:

nospacebetween“mm”and“Hg”]

-LikewiseformmH2O[note:

nospacebetween“mm”and“H2O”]

-TemperaturesaregivenindegreesCelsius,e.g.33°

C[note:

nospacebetweennumberanddegreesymbol]

-Virgule(/)isused,e.g.74beats/minNOT74beatsmin–1

-Eitheruse74beatsperminuteor74beats/min.

-Litreisalwaysacapitalletter“L”,e.g.mL/sec

4.9.Miscellaneousstylepoints

-Whenwithinparentheses,use“vs.”,e.g.(malevs.female)[note:

vs.isitalicizedwithendperiod]

-WhenNOTwithinparentheses,spellitout,e.g.maleversusfemale[note:

notitalicized]

-e.g.NOTe.g.,[note:

nocomma]

-i.e.NOTi.e.,[note:

-Orderofparenthesesshouldbeusedasbelow:

-95%confidenceinterval(CI)…

-efitinib[Iressa(ZD1839);

AstraZenecaPharmaceuticals,Wilmington,DE,USA]

-Italicizeallforeign-languageterms,e.g.invivo,invitro,inutero,enbloc,etc.

-Italicizespeciesnames,e.g.KlebsiellapneumoniaeandEscherichiacoliwerefoundin…

-“st”,“nd”,“rd”,“th”aresuperscriptedafternumberse.g.1st,2nd,3rd,4th

-Useendashesforrangeintext

-Useclosed-upemdashesforparentheticaldashes

-Ensureuseofhyphensisconsistentthroughout

-Userepetitive/serialunits,e.g.60%,74%and25%NOT60,74and25%

-Contractionsdonothaveendperiod,e.g.DrNOTDr.,MrNOTMr.

-Quotes:

doublequotesareused;

singlequotesusedforquoteswithinaquote

-Forequipment,software,chemicalreagents,etc.,completedetailsofthemanufacturershouldbeprovided,e.g.

-SPSSversion11(SPSSInc.,Chicago,IL,USA)

-ORifnameofproductappearswithinparentheses:

-(SPSSversion11;

SPSSInc.,Chicago,IL,USA)

5.BACKMATTER

5.1.Acknowledgements

-LevelIsectionheading“Acknowledgments”isspelledwithan“e”after“g”

-Positionedaftermainbodyoftext,BEFOREthereferences

5.2.References

-LevelIsectionheading“References”

-I

展开阅读全文
相关资源
猜你喜欢
相关搜索
资源标签

当前位置:首页 > 自然科学 > 物理

copyright@ 2008-2023 冰点文库 网站版权所有

经营许可证编号:鄂ICP备19020893号-2